Differential carbohydrate recognition by Campylobacter jejuni strain 11168: Influences of temperature and growth conditions

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Day, Christopher J ^a   Tiralongo, Joe ^a   Hartnell, Regan D ^a   Logue, Carie Anne ^a   Wilson, Jennifer C ^a   von Itzstein, Mark ^a   Korolik, Victoria ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; FUCOSE; GALACTOSE; GLYCAN; LECTIN; MANNOSE; N ACETYLNEURAMINIC ACID; OXYGEN; SIALIC ACID;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; BINDING KINETICS; CAMPYLOBACTER JEJUNI; CARBOHYDRATE ANALYSIS; CELL STRAIN CACO 2; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; GENE SEQUENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROARRAY ANALYSIS; MOLECULAR RECOGNITION; NONHUMAN; ROOM TEMPERATURE; BINDING SITE; CARBOHYDRATE METABOLISM; CELL ADHESION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOLECULAR GENETICS; TEMPERATURE;

CAMPYLOBACTER JEJUNI;

BACTERIAL ADHESION; BINDING SITES; CACO-2 CELLS; CAMPYLOBACTER JEJUNI; CARBOHYDRATE METABOLISM; CARBOHYDRATE SEQUENCE; CELL ADHESION; HUMANS; MOLECULAR SEQUENCE DATA; TEMPERATURE;

EID: 62849083844     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004927     Document Type: Article

References (59)

1. Crocker PR, Paulson JC, Varki A (2007) Siglecs and their roles in the immune system. Nat Rev Immunol 7: 255-266.
2. Sharon N (1996) Carbohydrate-lectin interactions in infectious disease. Adv Exp Med Biol 408: 1-8.
3. Gilboa-Garber N, Sudakevitz D (1999) The hemagglutinating activities of Pseudomonas aeruginosa lectins PA-IL and PA-IIL exhibit opposite temperature profiles due to different receptor types. FEMS Immunol Med Microbiol 25: 365-369.
4. Mitchell E, Houles C, Sudakevitz D, Wimmerova M, Gautier C, et al. (2002) Structural basis for oligosaccharide-mediated adhesion of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients. Nat Struct Biol 9: 918-921.
5. Wu AM, Wu JH, Singh T, Liu JH, Tsai MS, et al. (2006) Interactions of the fucose-specific Pseudomonas aeruginosa lectin, PA-IIL, with mammalian glycoconjugates bearing polyvalent Lewis(a) and ABH blood group glycotopes. Biochimie 88: 1479-1492.
6. Aspholm-Hurtig M, Dailide G, Lahmann M, Kalia A, Ilver D, et al. (2004) Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science 305: 519-522.
7. Boren T, Falk P, Roth KA, Larson G, Normark S (1993) Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262: 1892-1895.
8. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, et al. (1998) Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279: 373-377.
9. Mahdavi J, Sonden B, Hurtig M, Olfat FO, Forsberg L, et al. (2002) Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 297: 573-578.
10. Walz A, Odenbreit S, Mahdavi J, Boren T, Ruhl S (2005) Identification and characterization of binding properties of Helicobacter pylori by glycoconjugate arrays. Glycobiology 15: 700-708.
11. Thomas WE, Trintchina E, Forero M, Vogel V, Sokurenko EV (2002) Bacterial adhesion to target cells enhanced by shear force. Cell 109: 913-923.
12. Blixt O, Head S, Mondala T, canlan C, Huflejt ME, et al. (2004) Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. PNAS 101: 17033-17038.
13. Stevens J, Blixt O, Paulson JC, Wilson IA (2006) Glycan microarray technologies: tools to survey host specificity of influenza viruses. Nat Rev Microbiol 4: 857-864.
14. Angeloni S, Ridet JL, Kusy N, Gao H, Crevoisier F, et al. (2005) Glycoprofiling with micro-arrays of glycoconjugates and lectins. Glycobiology 15: 31-41.
15. Disney MD, Seeberger PH (2004) The use of carbohydrate microarrays to study carbohydrate-cell interactions and to detect pathogens. Chem Biol 11: 1701-1707.
16. Skirrow M (1991) Epidemiology of Campylobacter enteritis. Int J Food Microbiol 12: 9-16.
17. Blaser M (1997) Epidemiologic and clinical features of Campylobacter jejuni infections. J Infect Dis 176: S103-105.
18. Hazeleger WC, Wouters JA, Rombouts FM, Abee T (1998) Physiological activity of Campylobacter jejuni far below the minimal growth temperature. Appl Environ Microbiol 64: 3917-3922.
19. Parkhill J, Wren B, Mungall K, Ketley JM, Churcher C, et al. (2000) The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403: 665-668.
20. Ringoir DD, Korolik V (2003) Colonisation phenotype and colonisation potential differences in Campylobacter jejuni strains in chickens before and after passage in vivo. Vet Microbiol 92: 225-235.
21. Gaynor EC, Cawthraw S, Manning G, MacKichan JK, Falkow S, et al. (2004) The genome-sequenced variant of Campylobacter jejuni NCTC 11168 and the original clonal clinical isolate differ markedly in colonization, gene expression, and virulence-associated phenotypes. J Bacteriol 186: 503-517.
22. Guccione E,Del Rocio Leon-Kempis M, Pearson BM, Hitchin E, Mulholland F, et al. (2008) Amino-acid dependent growth of Campylobacter jejuni: Key roles for aspartase (AspA) under microaerobic and oxygen-limited conditions and identification of AspB (Cj0762), essential for growth on glutamate. Mol Microbiol.
23. Sharon N (2006) Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochim Biophys Acta 1760: 527-537.
24. Hugdahl MB, Beery JT, Doyle MP (1988) Chemotactic behavior of Campylobacter jejuni. Infect Immun 56: 1560-1566.
25. McAuley JL, Linden SK, Png CW, King RM, Pennington HL, et al. (2007) MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest 117: 2313-2324.
26. Morrow AL, Ruiz-Palacios GM, Altaye M, Jiang X, Guerrero ML, et al. (2004) Human milk oligosaccharide blood group epitopes and innate immune protection against campylobacter and calicivirus diarrhea in breastfed infants. Adv Exp Med Biol 554: 443-446.
27. Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS (2005) Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr 135: 1304-1307.
28. Cheng J, Yu H, Lau K, Huang S, Chokhawala HA, et al. (2008) Multi-functionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and transsialidase activities. Glycobiology 18: 686-697.
29. Danguy A, Camby I, Kiss R (2002) Galectins and cancer. Biochim Biophys Acta 1572: 285-293.
30. Demetter P, Nagy N, Martin B, Mathieu A, Dumont P, et al. (2008) The galectin family and digestive disease. J Pathol 215: 1-12.
31. Imberty A, wimmerova M, Mitchell EP, Gilboa-Garber N (2004) Structures of the lectins from Pseudomonas aeruginosa: insight into the molecular basis for host glycan recognition. Microbes Infect 6: 221-228.
32. Siebert HC, Andre S, Lu SY, Frank M, Kaltner H, et al. (2003) Unique conformer selection of human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins. Biochemistry 42: 14762-14773.
33. Grover V, Ghosh S, Sharma N, Chakraborti A, Majumdar S, et al. (2001) Characterization of a galactose specific adhesin of enteroaggregative Escherichia coli. Arch Biochem Biophys 390: 109-118.
34. Grover V, Ghosh S, Chakraborti A, Majumdar S, Ganguly NK (2007) Galactose-specific fimbrial adhesin of enteroaggregative Escherichia coli: a possible aggregative factor. Curr Microbiol 54: 175-179.
35. Hyland RM, Sun J, Griener TP, Mulvey GL, Klassen JS, et al. (2008) The bundlin pilin protein of enteropathogenic Escherichia coli is an N-acetyllactosamine-specific lectin. Cell Microbiol 10: 177-187.
36. Sung MA, Fleming K, Chen HA, Matthews S (2001) The solution structure of PapGII from uropathogenic Escherichia coli and its recognition of glycolipid receptors. EMBO Rep 2: 621-627.
37. Sung MA, Chen HA, Matthews S (2001) Sequential assignment and secondary structure of the triple-labelled carbohydrate-binding domain of papG from uropathogenic E. coli. J Biomol NMR 19: 197-198.
38. Cioci G, Mitchell EP, Gautier C, Wimmerova M, Sudakevitz D, et al. (2003) Structural basis of calcium and galactose recognition by the lectin PA-IL of Pseudomonas aeruginosa. FEBS Lett 555: 297-301.
39. Russell RG, Blake DC Jr (1994) Cell association and invasion of Caco-2 cells by Campylobacter jejuni. Infect Immun 62: 3773-3779.
40. Parry S, Hanisch FG, Leir SH, Sutton-Smith M, Morris HR, et al. (2006) N-Glycosylation of the MUC1 mucin in epithelial cells and secretions. Glycobiology 16: 623-634.
41. Thomas WE, Nilsson LM, Forero M, Sokurenko EV, Vogel V (2004) Shear-dependent 'stick-and-roll' adhesion of type 1 fimbriated Escherichia coli. Mol Microbiol 53: 1545-1557.
42. Gaynor EC, Ghori N, Falkow S (2001) Bile-induced 'pili' in Campylobacter jejuni are bacteria-independent artifacts of the culture medium. Mol Microbiol 39: 1546-1549.
43. McSweegan E, Walker RI (1986) Identification and characterization of two Campylobacter jejuni adhesins for cellular and mucous substrates. Infect Immun 53: 141-148.
44. Thomas CJ, Chizhov AO, Leitheiser CJ, Rishel MJ, Konishi K, et al. (2002) Solid-phase synthesis of bleomycin A(5) and three monosaccharide analogues: exploring the role of the carbohydrate moiety in RNA cleavage. J Am Chem Soc 124: 12926-12927.
45. Robbe C, Capon C, Coddeville B, Michalski J-C (2004) Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Journal of Biochemistry 384: 307-316.
46. Hanisch FG (2001) O-glycosylation of the mucin type. Biol Chem 382: 143-149.
47. Rhim AD, Stoykova L, Glick MC, Scanlin TF (2001) Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell. Glycoconj J 18: 649-659.
48. Newburg DS, Ruiz-Palacios GM, Morrow AL (2005) Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 25: 37-58.
49. Lehmann F, Tiralongo E, Tiralongo J (2006) Sialic acid-specific lectins: occurrence, specificity and function. Cell Mol Life Sci 63: 1331-1354.
50. Rhim AD, Kothari VA, Park PJ, Mulberg AE, Glick MC, et al. (2000) Terminal glycosylation of cystic fibrosis airway epithelial cells. Glycoconj J 17: 385-391.
51. Amano J, Kobayashi K, Oshima M (2001) Comparative study of glycosyltransferase activities in Caco-2 cells before and after enterocytic differentiation using lectin-affinity high-performance liquid chromatography. Arch Biochem Biophys 395: 191-198.
52. Gouyer V, Leteurtre E, Delmotte P, Steelant WF, Krzewinski-Recchi MA, et al. (2001) Differential effect of GalNAcalpha-O-bn on intracellular trafficking in enterocytic HT-29 and Caco-2 cells: correlation with the glycosyltransferase expression pattern. J Cell Sci 114: 1455-1471.
53. Kakiuchi Y, Tsuji S, Tsujii M, Murata H, Kawai N, et al. (2002) Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res 62: 1567-1572.
54. Linden SK, Driessen KM, McGuckin MA (2007) Improved in vitro model systems for gastrointestinal infection by choice of cell line, pH, microaerobic conditions, and optimization of culture conditions. Helicobacter 12: 341-353.
55. Malagolini N, Santini D, Chiricolo M, Dall'Olio F (2007) Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. Glycobiology 17: 688-697.
56. Isshiki S, Kudo T, Nishihara S, Ikehara Y, Togayachi A, et al. (2003) Lewis type 1 antigen synthase (beta3Gal-T5) is transcriptionally regulated by homeoproteins. J Biol Chem 278: 36611-36620.
57. Bradner JE, McPherson OM, Koehler AN (2006) A method for the covalent capture and screening of diverse small molecules in a microarray format. 1: 2344-2352.
58. Vetter D, Gallop MA (1995) Strategies for the synthesis and screening of glycoconjugates. 1. A library of glycosylamines. Bioconjug Chem 6: 316-318.
59. Logan RP, Robins A, Turner GA, Cockayne A, Borriello SP, et al. (1998) A novel flow cytometric assay for quantitating adherence of Helicobacter pylori to gastric epithelial cells. J Immunol Methods 213: 19-30.